InvestorsHub Logo
Post# of 253167
Next 10
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

Re: Whalatane post# 214463

Friday, 10/20/2017 3:16:49 PM

Friday, October 20, 2017 3:16:49 PM

Post# of 253167
ABEO:

At the R&D Day the MPS presenter said they would be enrolling the MPS IIIB study next week I believe and today there is a clinicaltrials entry.

https://clinicaltrials.gov/ct2/show/NCT03315182

BMRN's MPS IIIB program has initial very impressive biomarker data and initial signs of neurocognitive benefit. Still the route/frequency of administration is not without its challenges. I know payers wouldn't like it but hopefully the two could work synergistically one day and give these kids a better life!
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.